Sennoside A
Sennoside A has been studied in 2 papers since 2025: none in people yet, 2 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 14, 2026: “Anti-Malignancy and Anti-Inflammation Properties of Emodin, an Essential Constituent in Popular Laxative Botanicals”.
See all 2 papers on sennoside A
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Animals2
What did studies of sennoside A find?
1Studies of sennoside A measured one outcome, retinal degeneration.
Retinal degeneration
downin mice1
1 study
Retinal degeneration
downin mice1
Sennoside A decreases retinal degeneration in mice (light-induced).
“identified sennoside A as a candidate ALDH2 activator, which alleviated light-induced retinal degeneration in mice.”
Animalslight-induced
Detecting ALDH2 activity in live cells via conditional metabolic labeling
Chemical science
Latest
1 paper in 12 monthsThe American Journal of Chinese Medicine
Anti-Malignancy and Anti-Inflammation Properties of Emodin, an Essential Constituent in Popular Laxative Botanicals
Experiments in miceInterventions
Chemical Science
Detecting ALDH2 activity in live cells via conditional metabolic labeling
Experiments in miceAI & data